---
title: "PLTR 4Q25 First Take: Q4 was solid, with key metrics beating. Growth reaccelerated in Q4, easing con"
description: "PLTR 4Q25 First Take: Q4 was solid, with key metrics beating. Growth reaccelerated in Q4, easing concerns about the durability of the high-growth profile underpinning its rich multiple. 1) Headline re"
type: "topic"
locale: "en"
url: "https://longbridge.com/en/topics/38366103.md"
published_at: "2026-02-02T23:16:43.000Z"
author: "[Dolphin Research](https://longbridge.com/en/news/dolphin.md)"
---

# PLTR 4Q25 First Take: Q4 was solid, with key metrics beating. Growth reaccelerated in Q4, easing con

**PLTR 4Q25 First Take:** Q4 was solid, with key metrics beating. Growth reaccelerated in Q4, easing concerns about the durability of the high-growth profile underpinning its rich multiple.

**1) Headline results:** Revenue surged 70%, with QoQ acceleration, driven by US customers across Gov. and commercial. Adj. OP was nearly $800 mn, and OPM expanded sharply to 57%, up 4ppts QoQ, helped by higher product GPM and workforce efficiency.

GPM improved by 2ppts. Beyond mix shift, it also signals customer recognition of Palantir's product edge, supporting premium pricing.

The opex ratio also improved by 2ppts. Notably, a deepening partner ecosystem leverages partners' mature sales networks, helping Palantir trim near-term sales costs.

**2) By segment:** Growth was largely US-led, with commercial up 82% and Gov. up 60%, both meaningful contributors. Non-US regions remained in single-digit growth, with revenue mix down to 24%.

**3) Leading indicators:** Ample near- and long-term growth fuel. RPO, customer adds, and NDR all look healthy, capturing new demand and retention. Notably, after a pullback last quarter, RPO accelerated in Q4.

**4) Outlook:** Guidance for Q1 and 2026 corroborates those signals. It points to healthy growth, well ahead of Street expectations. $Palantir Tech(PLTR.US)

### Related Stocks

- [PLTR.US - Palantir Tech](https://longbridge.com/en/quote/PLTR.US.md)
- [UST.US - Pro Ultra 7-10Yrs](https://longbridge.com/en/quote/UST.US.md)
- [BY.US - Byline Bancorp](https://longbridge.com/en/quote/BY.US.md)
- [ALL.US - Allstate](https://longbridge.com/en/quote/ALL.US.md)
- [FT.US - Franklin Universal Trust](https://longbridge.com/en/quote/FT.US.md)
- [ALL-B.US - ALLSTATE CORP 5.1% PREF 15/01/2053](https://longbridge.com/en/quote/ALL-B.US.md)
- [ALL-H.US - ALLSTATE CORP DEP SHS REP 1/1000 NON CUM PER PRF SER H](https://longbridge.com/en/quote/ALL-H.US.md)
- [ALL-I.US - ALLSTATE CORP 4.750% DEP SHS REP 1/1000TH PRP PFD SR I](https://longbridge.com/en/quote/ALL-I.US.md)
- [ALL-J.US - ALLSTATE CORP DEP SHS REPSTG 1/1000TH NON PERP PFD SER](https://longbridge.com/en/quote/ALL-J.US.md)

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.